Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Dermatologic 1

Conditions

Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Peripheral Blood Stem Cell Transplantation 38fludarabine phosphate 34Cyclophosphamide 30Mycophenolic Acid 25Whole-Body Irradiation 22Cyclosporine 22Tacrolimus 21Busulfan 18Methotrexate 17Antilymphocyte Serum 16Radiotherapy 14Flow Cytometry 13Filgrastim 13Etoposide 13Vorinostat 10Methylprednisolone 10Bortezomib 10Bexarotene 10Melphalan 9Therapeutics 8Rituximab 8Psychiatric Rehabilitation 8Polymerase Chain Reaction 8Lenalidomide 8Gemcitabine 8romidepsin 7fludarabine 6Cord Blood Stem Cell Transplantation 6Brentuximab Vedotin 6tanespimycin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × Pentostatin × Dermatologic × Clear all
NCT00038025 2018-11-16

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 2 Completed
60 enrolled
DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Mycosis Fungoides, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡